EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ON CHEMOTHERAPY-INDUCED ORAL MUCOSITIS

被引：31

作者：

KATANO, M

NAKAMURA, M

MATSUO, T

IYAMA, A

HISATSUGU, T

机构：

[1] Department of Surgery, Saga Medical School, Saga, 849

来源：

SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1995年 / 25卷 / 03期

关键词：

ORAL MUCOSITIS; GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF); ADRIAMYCIN; CHEMOTHERAPY;

D O I：

10.1007/BF00311527

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

In this study, the ability of granulocyte colony-stimulating factor (G-CSF) to treat or prevent chemotherapy-induced oral mucositis in patients with advanced breast cancer was evaluated. A total of 14 patients who received intraarterial (i.a.) adriamycin (ADM) preoperatively were divided into two groups according to whether or not G-CSF was given. Thus, group A (n = 7) was given G-CSF and group B (n = 7) was not. G-CSF therapy reduced both the incidence and duration of ADM-induced oral mucositis, and a positive correlation was also seen between the incidence of mucositis and ADM-induced leukopenia (<2,000/mm(3)). Group A was further divided into two subgroups according to whether G-CSF was given after or before the leukopenia had dropped below 2,000/mm(3): group A-1 (n = 3) and group A-2 (n = 4), respectively. ADM-induced mucositis was observed in two of the three patients in group A-1, but in none of the four patients in group A-2. These results strongly support the idea that G-CSF can effectively treat and prevent ADM-induced oral mucositis.

引用

页码：202 / 206

页数：5

共 31 条

[11]

Hammond W.P., Price T.H., Souza L.M., Dale D.C., Treatment of cyclic neutropenia with granulocyte colony-stimulating factor, New England Journal of Medicine, 320, pp. 1306-1311, (1989)

[12]

Nicola N.A., Metcalf D., Biochemical properties of differentiation factors for murine myelomonocytic leukemia cells in organ conditioned media-separation from colony-stimulating factor, J Cell Physiol, 109, pp. 253-264, (1981)

[13]

Souza L.M., Boone T.C., Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C., Chazin V.R., Bruszewski J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M.A.S., Mertelsmann R., Welte K., Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells, Science, 232, pp. 61-65, (1986)

[14]

Bronchud M.H., Scarffe J.H., Thatcher N., Crowther D., Souza L.M., Alton M.K., Testa N.G., Dexter T.M., Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer, Br J Cancer, 56, pp. 809-813, (1987)

[15]

Morstyn G., Campbell L., Souza L.M., Alton N.K., Keech J., Green M., Sherdan W., Metcalf D., Effect of granulocyte colonystimulating factor on neutropenia induced by cytotoxic chemotherapy, Lancet, 1, pp. 667-672, (1988)

[16]

Hanada T., Ono I., Disappearance of neutropenia oscillation in a child with cyclic neutropenia after treatment with recombinant human granulocyte colony-stimulating factor, Eur J Haematol, 45, pp. 181-182, (1990)

[17]

Freund F., Luft S., Shoeber C., Heussner P., Schrezenmaier H., Porzsolt F., Welte K., Differential effect on GM-CSF and G-CSF in cyclic neutropenia, Lancet, 1, (1990)

[18]

Gabrilove J.L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M.A.S., Clarkson B., Oettgen H.F., Alton K., Welte K., Souza L., Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium, New Engl J Med, 318, pp. 1414-1422, (1988)

[19]

Miller A.B., Hoogstraten B., Staquet M., Winkler A., Reporting results of cancer treatment, Cancer, 47, pp. 207-214, (1981)

[20]

Oheda M., Hase S., Ono M., Ikenaga T., Structure of the sugar chains of recombinant human granulocyte colony-stimulating factor produced by Chinese hamster ovary cells, J Biochem, 103, pp. 544-546, (1988)

← 1 2 3 4 →